ConductScience.org, home

Paper · 198660

Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome.

Purtilo DT and 6 others. N Engl J Med, 1977. Cited by 222 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome. Papers, record 198660. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/198660

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome.
PubMed
Journal
N Engl J Med
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
222
iCite
Relative citation ratio, by iCite
6.12
iCite
Revised in PubMed
2010-11-18
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Purtilo DTD T
2DeFlorio D JrD
3Hutt LML M
4Bhawan JJ
5Yang JPJ P
6Otto RR
7Edwards WW

Source PubMed

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hematologic DiseasesMajor topic
Immunologic Deficiency SyndromesMajor topic
LymphomaMajor topic
Sex ChromosomesMajor topic
X ChromosomeMajor topic
Adolescent
B-Lymphocytes
Burkitt Lymphoma
Child
Child, Preschool
Female
Genes, Recessive
Genetic Linkage
Herpesvirus 4, Human
Humans
Infant
Infant, Newborn
Infectious Mononucleosis
Male
Pedigree

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 222 citations.

PMIDTitleJournalYearIn PapersSource
40,894,400Case Report: Hemophagocytic lymphohistiocytosis associated with NBAS gene variant and Epstein-Barr virus (EBV) infection.Front Pediatr2025https://conductscience.org/library/papers/40894400PubMed
39,117,809Genetics of Primary Hemophagocytic Lymphohistiocytosis.Adv Exp Med Biol2024https://conductscience.org/library/papers/39117809PubMed
37,426,667Approaching hemophagocytic lymphohistiocytosis.Front Immunol2023https://conductscience.org/library/papers/37426667PubMed
35,985,287From rare disorders of immunity to common determinants of infection: Following the mechanistic thread.Cell2022https://conductscience.org/library/papers/35985287PubMed
32,289,233Lethal Infectious Diseases as Inborn Errors of Immunity: Toward a Synthesis of the Germ and Genetic Theories.Annu Rev Pathol2021https://conductscience.org/library/papers/32289233PubMed
26,621,750Severe infectious diseases of childhood as monogenic inborn errors of immunity.Proc Natl Acad Sci U S A2015https://conductscience.org/library/papers/26621750PubMed
26,424,649Primary Immunodeficiencies Associated with EBV Disease.Curr Top Microbiol Immunol2015https://conductscience.org/library/papers/26424649PubMed
23,589,280Frequent mutations in SH2D1A (XLP) in males presenting with high-grade mature B-cell neoplasms.Pediatr Blood Cancer2013https://conductscience.org/library/papers/23589280PubMed
23,398,237Fulminant hemophagocytic lymphohistiocytosis secondary to a reactivated EBV infection: a case report.Ups J Med Sci2013https://conductscience.org/library/papers/23398237PubMed
23,300,447An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection.PLoS Pathog2012https://conductscience.org/library/papers/23300447PubMed

1 to 10 of 43

See all 43 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/198660

GET https://conductscience.org/api/papers/v1/198660/cited_by?page=2